PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942525F0221NOVEL nanotherapeutics — Eitr Biologics, Inc

Eitr Biologics, Inc holds $37.9M across 9 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 4 related awards under parent HT942523D0011. PoP ended Jun 30, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Army Med Res Acq Activity
Awarding office
Eitr Biologics, Inc
Recipient
Jun 30, 2026
PoP end
$300K
Obligated
$300K
Potential
541714
NAICS
AJ11
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Eitr Biologics, Inc — $90

Contract facts

Federal
Contract numberHT942525F0221
Also listed asHT9425-25-F-0221
Also listed asHT942523D0011-HT942525F0221
AgencyArmy Med Res Acq Activity
Awarding officeArmy Med Res Acq Activity
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentEitr Biologics, Inc
CAGE99JH0
UEIHX49LZLY32G5
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAJ11
Parent IDIQ / IDVHT942523D0011
Place of performanceSAN DIEGO CA
Pricing typeFirm Fixed Price
Extent competedNot Competed
Related solicitationHT942523R0061
PoP startJul 1, 2025
PoP end (current)Jun 30, 2026
Obligated$300K
Current value$300K
Potential value$300K

NOVEL NANOTHERAPEUTICS is a federal award for Army Med Res Acq Activity held by Eitr Biologics, Inc. Estimated value $300K ($300K obligated). Current period of performance ends Jun 30, 2026. Place of performance: SAN DIEGO CA. Related solicitation HT942523R0061.

Recompete timing

Public
Past PoP end (52 days ago)

Current PoP ended Jun 30, 2026 (52 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Eitr Biologics, Inc$37.9M obligated across 9 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($37.9M) · all agencies
Department of Health and Human Services (HHS)$33.1M · 87%Department of Defense (DOD)$4.9M · 13%
Open full company profile

Related awards

Same parent · incumbent
HT942524P0015
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AN…
$730K
Dec 10, 2026
HT942626FE033
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
$270K
Mar 31, 2027
75A50123C00060
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTI…
$33.1M
Sep 30, 2027
HT942526FE010
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
$927K
Dec 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT942525F0221?

HT942525F0221 (NOVEL nanotherapeutics) is a Army Med Res Acq Activity award with a potential value of $300K, currently held by Eitr Biologics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9425-25-F-0221?

HT9425-25-F-0221 is the dashed form of PIID HT942525F0221 (NOVEL nanotherapeutics), held by Eitr Biologics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT942525F0221?

Army Med Res Acq Activity awarded HT942525F0221 to Eitr Biologics, Inc (potential $300K).

Who is the incumbent on HT942525F0221?

Eitr Biologics, Inc is the incumbent with $37.9M across 9 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2026.

When does Eitr Biologics, Inc’s HT942525F0221 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT942525F0221